Esperion Therapeutics Provides Clinical Development and Regulatory Update for Bempedoic Acid
28 juin 2016 16h05 HE
|
Esperion Therapeutics, Inc.
On track to initiate global pivotal Phase 3 studies and CVOT in the fourth quarter Aligned with global regulatory authorities on a consistent definition of statin intolerance Conference...